Targeted Therapies for Solid Tumors

In the race to find new oncology treatments, solid tumor clinical trials are continuing to pave the way in the discovery and approval of effective new anti-cancer therapies including immunotherapies and other forms of innovative targeted approaches.

These new treatment paradigms require a deep therapeutic understanding and a high level of experience in the different therapeutic targets. Against evolving treatment landscapes and a backdrop of regulatory change, patient recruitment and retention require a specialist approach: one where the ability to connect with patients through investigative sites ranks as highly as medical and operational expertise.

As the CRO that investigators consistently choose to work with*, Syneos Health™ will match your commitment to making a success of your trials.

パンフレットをダウンロード